Europe — EMA
Gensulin M30 (30/70) (Insulin Human Biphasic)
Gensulin M30 (30/70) is a biphasic insulin human formulation designed for subcutaneous use. It combines rapid and intermediate-acting insulin to manage blood gl
Request sourcing
What is Insulin Human Biphasic?
Gensulin M30 (30/70) is a biphasic insulin human formulation designed for subcutaneous use. It combines rapid and intermediate-acting insulin to manage blood glucose levels in diabetes care.
What is Insulin Human Biphasic used for?
Gensulin M30 (30/70) is primarily used for managing blood sugar levels in individuals with diabetes. This biphasic insulin formulation provides both immediate and prolonged glucose control, making it suitable for daily diabetes management. It is often prescribed to help regulate insulin levels in the body, supporting overall diabetes care.
What are the side effects of Insulin Human Biphasic?
Common effects of Gensulin M30 (30/70) may include localized reactions at the injection site, such as redness or itching. Some users might experience hypoglycemia if blood sugar levels drop too low. These effects vary among individuals and typically subside over time.
What precautions apply to Insulin Human Biphasic?
Gensulin M30 (30/70) should be stored according to the manufacturer's guidelines to maintain its efficacy. It is important to use this medication as directed by a healthcare professional. Always check the label for storage instructions and handle with care to avoid contamination.
What does Insulin Human Biphasic interact with?
Gensulin M30 (30/70) may interact with certain medications, including oral hypoglycemic agents and other drugs that affect blood sugar levels. Alcohol consumption can also influence its effectiveness. It is advisable to consult a healthcare provider about potential interactions before starting this medication.



